Company Overview of Adheron Therapeutics, Inc.
Adheron Therapeutics, Inc. develops pharmaceuticals for the treatment of rheumatoid arthritis and fibrotic diseases. Its product SDP051, is a Cad-11 antagonist that acts as an adhesive between cells and changes in these Cad-11 interactions can induce the cells to produce many proteins that influence the cellular environment positively or adversely. The company's product is used in pulmonary fibrosis and skin fibrosis. Adheron Therapeutics, Inc. was formerly known as Synovex Corporation. The company was incorporated in 2003 and is based in Berkeley, Massachusetts.
2930 Domingo Avenue
Mail Boxes Plus
Mail Box 104
Berkeley, MA 94705
Founded in 2003
Key Executives for Adheron Therapeutics, Inc.
Adheron Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Radiation Therapies, L.L.C.||United States|
|IDDC Corporation||United States|
|ZeaVision LLC||United States|
|Vitarich Laboratories, Inc.||United States|
|Nascime Limited||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Fredericksburg, VA | AstellasPosted: Mar 07
- Princeton, NJ | RGPPosted: Mar 05
- Missouri | AstellasPosted: Feb 21
- Fresno, CA | AstellasPosted: Feb 20
Sponsored Financial Commentaries
To contact Adheron Therapeutics, Inc., please visit adherontherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.